chr1-113585502-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_001142782.2(MAGI3):c.669G>A(p.Thr223=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00304 in 1,614,008 control chromosomes in the GnomAD database, including 140 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.016 ( 78 hom., cov: 31)
Exomes 𝑓: 0.0017 ( 62 hom. )
Consequence
MAGI3
NM_001142782.2 synonymous
NM_001142782.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.550
Genes affected
MAGI3 (HGNC:29647): (membrane associated guanylate kinase, WW and PDZ domain containing 3) Predicted to enable frizzled binding activity. Predicted to be involved in signal transduction. Predicted to act upstream of or within positive regulation of JUN kinase activity. Located in cell junction. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.64).
BP6
Variant 1-113585502-G-A is Benign according to our data. Variant chr1-113585502-G-A is described in ClinVar as [Benign]. Clinvar id is 788941.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.55 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0541 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MAGI3 | NM_001142782.2 | c.669G>A | p.Thr223= | synonymous_variant | 4/21 | ENST00000307546.14 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MAGI3 | ENST00000307546.14 | c.669G>A | p.Thr223= | synonymous_variant | 4/21 | 5 | NM_001142782.2 | ||
MAGI3 | ENST00000369617.8 | c.669G>A | p.Thr223= | synonymous_variant | 4/22 | 1 | |||
MAGI3 | ENST00000369611.4 | c.669G>A | p.Thr223= | synonymous_variant | 4/21 | 1 | P1 | ||
MAGI3 | ENST00000369615.5 | c.669G>A | p.Thr223= | synonymous_variant | 4/22 | 5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0162 AC: 2465AN: 152048Hom.: 78 Cov.: 31
GnomAD3 genomes
AF:
AC:
2465
AN:
152048
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00429 AC: 1076AN: 251068Hom.: 23 AF XY: 0.00290 AC XY: 393AN XY: 135684
GnomAD3 exomes
AF:
AC:
1076
AN:
251068
Hom.:
AF XY:
AC XY:
393
AN XY:
135684
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00167 AC: 2436AN: 1461842Hom.: 62 Cov.: 31 AF XY: 0.00147 AC XY: 1069AN XY: 727218
GnomAD4 exome
AF:
AC:
2436
AN:
1461842
Hom.:
Cov.:
31
AF XY:
AC XY:
1069
AN XY:
727218
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0163 AC: 2477AN: 152166Hom.: 78 Cov.: 31 AF XY: 0.0157 AC XY: 1167AN XY: 74394
GnomAD4 genome
AF:
AC:
2477
AN:
152166
Hom.:
Cov.:
31
AF XY:
AC XY:
1167
AN XY:
74394
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
16
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at